0
0
10/19/22 at 6:05am
Organization
Pulmonologyadvisor.com
Author
melissaalvarez
35 words
0
Comments
Can upfront empiric community-acquired pneumonia antimicrobial therapy reduce ventilator-associated pneumonia rates in patients with COVID-19 requiring MV?
You are the first to view
https://www.pulmonologyadvisor.com/home/meetings/chest-2022/upfront-empiric-cap-antimicrobial-therapy-linked-to-less-vap-in-severe-covid-19/
Create an account
or login to join the discussion